Appel à projets H2020 "Innovative Medicine Initiatives"
p2 |
!!! Submission of first-stage proposals was extended to 12 May 2020 !!!
DL: 12/05/2020 (pre-proposal) - Closing date of the call "Innovative Medicines Initiatives 2020"
The Innovative Medicines Initiative (IMI) is launching a new Call for proposals with funding opportunities in cancer, tuberculosis, vaccines, psoriatic arthritis and drugs based on proteins.
IMI will contribute EUR 133 million to the projects funded under the Call. These funds come from Horizon 2020 and will support the participation in the projects of organisations such as universities, small and medium-sized enterprises, and patient groups. EFPIA companies and IMI Associated Partners will contribute EUR 140 million, mostly as ‘in kind’ contributions (e.g. staff time, access to equipment, etc.).
Call ID
H2020-JTI-IMI2-2020-20-two-stage
Action Type
RIA – Research and Innovation Actions
Topics
- Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
- Topic 2: Innovations to accelerate vaccine development and manufacture
- Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
This topic is part of the IMI AMR Accelerator Programme.
Applicants should also read the Questions and Answers on the programme (document last updated November 2019). - Topic 4: Tumour plasticity
- Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy
- Topic 6: Handling of protein drug products and stability concerns
For full details of the topics, including the budget breakdown and the General Conditions for the Call for proposals, click on the links above (which take you directly to the relevant page of the Participant Portal) or read the IMI2 - Call 20 Text
Deadlines
- Stage 1 submission deadline: 12 May 2020
- Stage 2 submission deadline: 5 November 2020
Contact UCLouvain
Ms. Mahdia ABDELOUAHAB (ADRE / RINT) - Phone: +32 (0)10 47.24.80, is available to UCLouvain partners for any additional information about this call: eligibility, assistance in setting up the project, budget verification, thematic review (non-scientific).